08.04.20
The American Herbal Products Association (AHPA), a trade group with a long history of guiding herbal products companies to best practices in business and responsible herb commerce, will be hosting its second annual Hemp-CBD Virtual Congress, which will be taking place on Aug. 27 from 8 a.m. to 3:30 p.m. PST to provide guidance to this rapidly growing, yet uncertain market segment.
AHPA’s Cannabis Committee, which formed over 10 years ago, leverages AHPA’s expertise in working with regulatory agencies and other institutions that impact the herbal products industry. The hemp and CBD market is new, and exists within an evolving and inconsistent regulatory climate, and AHPA reports that it has much to offer through its experience in taking other herbal products from unregulated to well-established and thriving.
The Hemp-CBD Congress has assembled over 20 experts to discuss the vulnerabilities companies face from an agricultural, regulatory, manufacturing, and marketing point of view. This includes financial and regulatory snapshots which will help to inform product development, agricultural strategy, and marketing initiatives. Multiple opportunities for attendee interaction with the industry experts will be included in the Virtual Congress agenda.
“We’re pleased to have FTC, USDA, Senator Ron Wyden, and many hemp industry leaders share their expert and candid comments on where the industry is headed and pitfalls to avoid along the way,” Asa Waldstein, senior vice president of functional remedies and AHPA Cannabis Committee chair, said. “A lot can go wrong when operating a hemp-CBD company, and this agenda hits all the areas of vulnerability that must be planned for.”
“This segment of the industry has grown extremely fast, attracting people with varying levels of experience with the dietary supplements marketplace and the relevant regulatory agencies,” Michael McGuffin, AHPA president, said. “For AHPA, hemp and CBD products are another in a long list of herbs we have helped companies build businesses upon, and the same levels of expertise that we have guided other companies in acquiring are available to new members as well.”
Information on the agenda, the speakers, and registration can be found here.
AHPA’s Cannabis Committee, which formed over 10 years ago, leverages AHPA’s expertise in working with regulatory agencies and other institutions that impact the herbal products industry. The hemp and CBD market is new, and exists within an evolving and inconsistent regulatory climate, and AHPA reports that it has much to offer through its experience in taking other herbal products from unregulated to well-established and thriving.
The Hemp-CBD Congress has assembled over 20 experts to discuss the vulnerabilities companies face from an agricultural, regulatory, manufacturing, and marketing point of view. This includes financial and regulatory snapshots which will help to inform product development, agricultural strategy, and marketing initiatives. Multiple opportunities for attendee interaction with the industry experts will be included in the Virtual Congress agenda.
“We’re pleased to have FTC, USDA, Senator Ron Wyden, and many hemp industry leaders share their expert and candid comments on where the industry is headed and pitfalls to avoid along the way,” Asa Waldstein, senior vice president of functional remedies and AHPA Cannabis Committee chair, said. “A lot can go wrong when operating a hemp-CBD company, and this agenda hits all the areas of vulnerability that must be planned for.”
“This segment of the industry has grown extremely fast, attracting people with varying levels of experience with the dietary supplements marketplace and the relevant regulatory agencies,” Michael McGuffin, AHPA president, said. “For AHPA, hemp and CBD products are another in a long list of herbs we have helped companies build businesses upon, and the same levels of expertise that we have guided other companies in acquiring are available to new members as well.”
Information on the agenda, the speakers, and registration can be found here.
